Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nrc Health (NRC) Non-Current Debt (2016 - 2026)

Nrc Health's Non-Current Debt history spans 16 years, with the latest figure at $75.0 million for Q4 2025.

  • On a quarterly basis, Non-Current Debt rose 29.58% to $75.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $75.0 million, a 29.58% increase, with the full-year FY2025 number at $75.0 million, up 29.58% from a year prior.
  • Non-Current Debt hit $75.0 million in Q4 2025 for Nrc Health, down from $76.0 million in the prior quarter.
  • Over the last five years, Non-Current Debt for NRC hit a ceiling of $77.0 million in Q2 2025 and a floor of $14.2 million in Q3 2023.
  • Historically, Non-Current Debt has averaged $34.6 million across 5 years, with a median of $25.0 million in 2021.
  • Biggest five-year swings in Non-Current Debt: dropped 24.81% in 2023 and later surged 217.07% in 2024.
  • Tracing NRC's Non-Current Debt over 5 years: stood at $22.3 million in 2021, then fell by 20.56% to $17.7 million in 2022, then skyrocketed by 66.59% to $29.5 million in 2023, then surged by 96.45% to $57.9 million in 2024, then increased by 29.58% to $75.0 million in 2025.
  • Business Quant data shows Non-Current Debt for NRC at $75.0 million in Q4 2025, $76.0 million in Q3 2025, and $77.0 million in Q2 2025.